Widening of the excitable gap and enlargement of the core of reentry during atrial fibrillation with a pure sodium channel blocker in canine atria

Circulation

Volumn 107, Issue 6, 2003, Pages 905-910

  Kawase, Ayaka ^a   Ikeda, Takanori ^a,c   Nakazawa, Kazuo ^b   Ashihara, Takashi ^b   Namba, Tsunetoyo ^b   Kubota, Tetsuya ^a   Sugi, Kaoru ^a   Hirai, Hironori ^a  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Working Grp Cardiac Simulat/Map   (Japan)

^c KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Excitable gap; Mapping; Pilsicainide; Sodium channel blockers

Indexed keywords

ACETYLCHOLINE; PILSICAINIDE; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL TISSUE; ANISOTROPY; ARTICLE; CONTROLLED STUDY; DOG; DRUG MECHANISM; ENDOCARDIUM; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART CONTRACTION; HEART ELECTROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; REENTRY ARRHYTHMIA;

ACETYLCHOLINE; ANIMALS; ATRIAL FIBRILLATION; BODY SURFACE POTENTIAL MAPPING; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART ATRIA; LIDOCAINE; MALE; MEMBRANE POTENTIALS; SODIUM CHANNEL BLOCKERS;

EID: 0037448794     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000050148.72502.3A     Document Type: Article

References (19)

1. Kodama I, Ogawa S, Inoue H, et al. Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian gambit. Jpn Circ J. 1999;63:1-12.
2. Atrashi H, Inoue H, Hiejima K, et al. Conversion of recent-onset fibrillation by a single oral dose of pilsicainide (Pilsicainide Suppression Trial on Atrial Fibrillation). Am J Cardiol. 1996;78:694-697.
3. Shinagawa K, Mitamura H, Takeshita A, et al. Determination of refractory periods and conduction velocity during atrial fibrillation using atrial capture in dogs. J Am Coil Cardiol. 2000;35:246-253.
4. Hayashi H, Fujiki A, Tani M, et al. Different effects of class Ic and III antiarrhythmic drugs on vagotonic atrial fibrillation in the canine heart. J Cardiovasc Pharmacol. 1998;31:101-107.
5. Iwasa A, Okumura K, Tabuchi T, et al. Effects of pilsicainide and propafenone on vagally induced atrial fibrillation: role of suppressant effect in conductivity. Eur J Pharmacol. 1998;356:31-40.
6. Wijffels MCEF, Dorland R, Mast F, et al. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation. 2000;102:260-267.
7. Ikeda T, Kawase A, Nakazawa K, et al. Role of structural complexities of septal tissue in maintaining ventricular fibrillation in isolated, perfused canine ventricle. J Cardiovasc Electrophysiol. 2001;12:66-75.
8. Duytschaever M, Mast F, Killian M, et al. Methods for determining the refractory period and excitable gap during persistent atrial fibrillation in the goat. Circulation. 2001;104:957-962.
9. Cabo C, Pertsov AM, Baxter WT, et al. Wavefront curvature as a cause of slow conduction and block in isolated cardiac muscle. Circ Res. 1994;75:1014-1028.
10. Rensma PL, Allessie MA, Lammers WJEP, et al. Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circulation. 1988;62:395-410.
11. Kirchhof C, Wijffels M, Brugada J, et al. Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol. 1991;17:116-124.
12. Weirich J, Hohnloser S, Antoni H. Differential analysis of frequency-dependent effects of antiarrhythmic drugs: importance of the saturation behavior of frequency-dependent sodium-channel blockade. J Cardiovasc Pharmacol. 1992;20(suppl 2):S8-S16.
13. Mandapati R. Asano Y, Baxter WT, et al. Quantification of effects of global ischemia on dynamics of ventricular fibrillation in isolated rabbit heart. Circulation. 1998;98:1688-1696.
14. Cosio FG, Delpon E. New antiarrhythmic drugs for atrial flutter and atrial fibrillation: a conceptual breakthrough at last? Circulation. 2002;105:276-278.
15. Ikeda T, Uchida T, Hough D, et al. Mechanism of spontaneous termination of functional reentry in isolated canine right atrium: evidence for the presence of an excitable but nonexcited core. Circulation. 1996;94:1962-1973.
16. Wu T-J, Yashima M, Xie F, et al. Role of pectinate muscle bundles in the generation and maintenance of intra-atrial reentry: potential implications for the mechanism of conversion between atrial fibrillation and atrial flutter. Circ Res. 1998;83:448-462.
17. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339:659-666.
18. Wu T-J, Kim YH, Yashima M, et al. Progressive action potential duration shortening and the conversion from atrial flutter to atrial fibrillation in the isolated canine right atrium. J Am Coll Cardiol. 2001;15:1757-1765.
19. Schuessler RB, Grayson TM, Bromberg BI, et al. Cholinergically mediated tachyarrhythmias induced by a single extrastimulus in the isolated canine right atrium. Circ Res. 1992;71:1254-1267.